Sarepta Therapeutics
SRPT
SRPT
114 hedge funds and large institutions have $321M invested in Sarepta Therapeutics in 2015 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 37 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
10% less capital invested
Capital invested by funds: $355M → $321M (-$34.4M)
30% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 20
Holders
114
Holding in Top 10
1
Calls
$37.3M
Puts
$9.47M
Top Buyers
| 1 | +$6.64M | |
| 2 | +$6.14M | |
| 3 | +$4.38M | |
| 4 |
Renaissance Technologies
New York
|
+$3.08M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$3.07M |
Top Sellers
| 1 | -$8.07M | |
| 2 | -$5.64M | |
| 3 | -$5.37M | |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$5.03M |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$2.53M |